$ZWS

Zurn Elkay (NYSE:ZWS) posts Q3 2026 sales in line with estimates but stock drops

Zurn Elkay reported Q3 2026 revenue of $495.1M, matching estimates and showing 8.7% YoY growth. Adjusted EPS was $0.52, a 4.2% beat. Q4 guidance was mixed, with revenue below estimates but EBITDA above. Operating margin improved to 21.9% from 17% YoY. Organic revenue rose 7% YoY.

Original reporting
Published Oct 27, 2026, 8:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 8:56 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Zurn Elkay (NYSE:ZWS) posts Q3 2026 sales in line with estimates but stock drops — source image
Decision brief

The 30-second read

$ZWSBearishMed
01

Why it matters

The mixed results triggered a stock decline despite an EPS beat, highlighting the market's focus on forward guidance.

02

Market read

Earnings release with guidance miss is a primary catalyst for short-term price movement.

03

What to watch

Organic revenue growth of 7% YoY suggests underlying demand remains healthy.

Relevance 8/10Novelty 8/10Timing: post-market today

Background

Zurn Elkay (NYSE:ZWS) is a provider of water infrastructure products. The company posted Q3 2026 results with revenue matching estimates but issued lower-than-expected Q4 guidance.

Company-level read

Ticker impact

$ZWSBearishHigh confidence
Context

Zurn Elkay reported Q3 2026 results with revenue in line and guidance below estimates, causing the stock to drop.

Expected impact

likely further decline as market prices in weaker guidance

Evidence & confidence

Guidance below consensus outweighs modest EPS beat, prompting sell pressure.

Market effects

Water infrastructure sector may see modest pullback as earnings miss signals demand softness.

U.S. small-cap indices could face slight pressure.

Limited, primarily affects U.S. investors.

Counterpoint

The EPS beat and strong margin expansion could support a rebound if guidance is revised.

Key entities

  • Zurn Elkay

    Water infrastructure manufacturer reporting Q3 earnings.

Related articles

$ZWSHighAI 8/10

Zurn Elkay Water Solutions earnings beat by $0.02, revenue topped estimates

Zurn Elkay Water Solutions (ZWS) reported Q2 EPS of $0.52, beating estimates by $0.02, with revenue of $495M, slightly above expectations. The company provided Q4 2026 revenue guidance of $430M-$437M, below the consensus of $438.10M. ZWS stock is down 2.69% over the last 3 months but up 6.84% year-over-year. The company's Financial Health score is rated as 'great performance' according to InvestingPro.

$ZWSHigh

Zurn Elkay Water Solutions Reports Third Quarter 2026 Financial Results

Zurn Elkay Water Solutions Corp (ZWS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Press Release October 27, 2026 Contact Information: For Immediate Release Bobbi Belstner Vice President, Corporate Controller 414.361.0122 Zurn Elkay Water Solutions Reports Third Quarter 2026 Financial Results Investor call scheduled for Wednesday, October 28, 2026

$ZWSMed

Stifel cuts Zurn Water Solutions stock price target on construction outlook

Stifel reduced its price target for Zurn Water Solutions (ZWS) to $56 from $62, keeping a Buy rating. The stock is currently at $47.06, with 9 analysts revising earnings upwards. ZWS reported Q2 2026 earnings of $0.50 per share, beating estimates, and revenue of $491 million, also above forecasts. The company has a strong financial health and expects stable demand and improved pricing in 2H 2026.

$AAONMed

Q2 Earnings Highlights: A.O. Smith (NYSE:AOS) Vs The Rest Of The HVAC and Water Systems Stocks

AAON (NYSE:AOS) beat analyst estimates and reported fastest revenue growth among HVAC peers, but its stock is down 19.2%. Lennox (NYSE:LII) missed revenue expectations, with stock down 29.4%. Trane Technologies (NYSE:TT) and Zurn Elkay (NYSE:ZWS) both exceeded revenue estimates, but their stocks are down 1.5% and 7.7% respectively. Market focus has shifted from AI to geopolitics and back to fundamentals.

$ZWSMed

Zurn Elkay Water Solutions Cor Q2 Earnings Call Highlights

Zurn Elkay Water Solutions (NYSE: ZWS) reported Q2 call highlights, including $48M cash from IEPA and reciprocal tariff refunds, with $60M remaining uncollected. Net debt leverage ended at 0.3x. It completed the $109M Intellihot acquisition, targeting $37M sales in 2026 and raised 2026 outlook: adj. EBITDA $503M-$513M and FCF at least $350M (excluding refunds).

$ZWSMed

ZWS: Record Q2 growth and margins, boosted by Intellihot acquisition and raised full-year outlook

Zurn Elkay Water Solutions (ZWS) reported Q2 2026 results with 10% organic sales growth and record EBITDA margins, citing strength in Water Safety, Drinking Water, and Flow Systems. The company said its Intellihot acquisition expands its addressable market. ZWS also raised its full-year guidance for sales, EBITDA, and free cash flow, according to its Q2 2026 transcript.